Major hepatic resection may suppress the growth of tumours remaining in the residual liver

Article metrics

Abstract

Little is known as to how hepatectomy is associated with the growth of hepatic tumours, which may reside in the remaining liver after curative resection for hepatocellular carcinoma. Using an intra-hepatic tumour implantation model in rats, the effects of hepatectomy on tumour growth in the remaining liver were investigated. On post-operative day 7, the tumour weight in the remaining liver following 30% hepatectomy was 0.321 ± 0.058 g (mean ± SD) which was significantly greater than that (0.245 ± 0.040 g) in sham operations (P < 0.05). However, the tumour weight (0.156 ± 0.067 g) in the remaining liver following 60% hepatectomy was significantly lower than that in sham animals (P < 0.005). The number of TdT-mediated dUTP nick-end labelling (TUNEL) positive tumour cells was significantly increased in 60% hepatectomy as compared with the sham and 30% hepatectomy group. The mRNA expression of TGF-β1, TNF-α and Fas in the tumour portion of 60% hepatectomy, was higher than that in 30% hepatectomy group. Plasma levels of TGF-β1 were inversely correlated with intra-hepatic tumour weights. These results suggest that major hepatic resection may lead to an increased induction of apoptosis for the remaining hepatic tumour. © 2000 Cancer Research Campaign

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  1. Ashley DM, Kong FM, Bigner DD and Hale LP (1998) Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model. Cancer Res 58: 302–309

  2. Bayon LG, Izquierdo MA, Sirovich I, van Rooijen N, Beelen RH and Meijer S (1996) Role of Kupffer cells in arresting circulating tumor cells and controlling metastatic growth in the liver. Hepatology 23: 1224–1231

  3. Castillo MH, Doerr RJ, Paolini N Jr, Cohen S and Goldrosen M (1989) Hepatectomy prolongs survival of mice with induced liver metastases. Arch Surg 124: 167–169

  4. de Jong KP, Lont HE, Bijma AM, Brouwers MA, de Vries EG, van Veen ML, Marquet RL, Slooff MJ and Terpstra OT (1995) The effect of partial hepatectomy on tumor growth in rats: in vivo and in vitro studies. Hepatology 22: 1263–1272

  5. Doerr R, Castillo M, Evans P, Paolini N, Goldrosen M and Cohen SA (1989) Partial hepatectomy augments the liver’s antitumor response. Arch Surg 124: 170–174

  6. Ezaki T, Yukaya H, Ogawa Y, Chang YC and Nagasue N (1989) Recurrent form of hepatocellular carcinoma after partial hepatic resection. Hepatogastroenterology 36: 164–167

  7. Fan G, Kren BT and Steer CJ (1998) Regulation of apoptosis-associated genes in the regenerating liver. Semin Liver Dis 18: 123–140

  8. Farges O, Morris PJ and Dallman MJ (1995) Spontaneous acceptance of rat liver allografts is associated with an early downregulation of intragraft interleukin-4 messenger RNA expression. Hepatology 21: 767–775

  9. Gavrieli Y, Sherman Y and Ben-Sasson SA (1992) Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493–501

  10. Grasl-Kraupp B, Ruttkay-Nedecky B, Mullauer L, Taper H, Huber W, Bursch W and Schulte-Hermann R (1997) Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 25: 906–912

  11. Higaki K, Yano H and Kojiro M (1996) Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. Am J Pathol 149: 429–437

  12. Higgins GM and Anderson RM (1931) Experimental pathology of the liver; restoration of the liver of the white rat following partial surgical removal. Arch Pathol 12: 186–202

  13. Kimura K, Wakatsuki T and Yamamoto M (1994) A variant mRNA species encoding a truncated form of Fas antigen in the rat liver. Biochem Biophys Res Commun 198: 666–674

  14. Kosuge T, Makuuchi M, Takayama T, Yamamoto J, Shimada K and Yamasaki S (1993) Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology 40: 328–332

  15. Lin JK and Chou CK (1992) In vitro apoptosis in the human hepatoma cell line induced by transforming growth factor beta 1. Cancer Res 52: 385–388

  16. Mizutani J, Hiraoka T, Yamashita R and Miyauchi Y (1992) Promotion of hepatic metastases by liver resection in the rat. Br J Cancer 65: 794–797

  17. Nagao T, Inoue S, Yoshimi F, Sodeyama M, Omori Y, Mizuta T, Kawano N and Morioka Y (1990) Postoperative recurrence of hepatocellular carcinoma. Ann Surg 211: 28–33

  18. Ono M, Tanaka N and Orita K (1986) Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression. Cancer Res 46: 5049–5053

  19. Owen-Schaub LB, Radinsky R, Kruzel E, Berry K and Yonehara S (1994) Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness. Cancer Res 54: 1580–1586

  20. Pan TL, Goto S, Lin YC, Lord R, Chiang KC, Lai CY, Chen YS, Eng HL, Cheng YF, Tatsuma T, Kitano S, Lin CL and Chen CL (1999) The Fas and Fas ligand pathways in liver allograft tolerance. Clin Exp Immunol 118: 180–187

  21. Patel T, Roberts LR, Jones BA and Gores GJ (1998) Dysregulation of apoptosis as a mechanism of liver disease: an overview. Semin Liver Dis 18: 105–114

  22. Picardo A, Karpoff HM, Ng B, Lee J, Brennan MF and Fong Y (1998) Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery 124: 57–64

  23. Shimada M, Takenaka K, Taguchi K, Fujiwara Y, Gion T, Kajiyama K, Maeda T, Shirabe K, Yanaga K and Sugimachi K (1998) Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 227: 80–85

  24. Slooter GD, Marquet RL, Jeekel J and Ijzermans JN (1995) Tumour growth stimulation after partial hepatectomy can be reduced by treatment with tumour necrosis factor alpha. Br J Surg 82: 129–132

  25. Strand S, Hofmann WJ, Hug H, Muller M, Otto G, Strand D, Mariani SM, Stremmel W, Krammer PH and Galle PR (1996) Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells – a mechanism of immune evasion?. Nat Med 2: 1361–1366

  26. Suda T, Takahashi T, Golstein P and Nagata S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169–1178

  27. Utsunomiya T, Matsumata T, Adachi E, Honda H and Sugimachi K (1992) Limitations of current preoperative liver imaging techniques for intrahepatic metastatic nodules of hepatocellular carcinoma. Hepatology 16: 694–701

  28. Vermijlen D, Luo D, Robaye B, Seynaeve C, Baekeland M and Wisse E (1999) Pit cells (Hepatic natural killer cells) of the rat induce apoptosis in colon carcinoma cells by the perforin/granzyme pathway. Hepatology 29: 51–56

  29. Webber EM, Godowski PJ and Fausto N (1994) In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 19: 489–497

  30. Wong GH and Goeddel DV (1994) Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol 152: 1751–1755

  31. Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555–556

  32. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Ozaki H, Yamaguchi N and Makuuchi M (1996) Recurrence of hepatocellular carcinoma after surgery. Br J Surg 83: 1219–1222

  33. Yang R, Rescorla FJ, Reilly CR, Faught PR, Sanghvi NT, Lumeng L, Franklin TD Jr and Grosfeld JL (1992) A reproducible rat liver cancer model for experimental therapy: introducing a technique of intrahepatic tumor implantation. J Surg Res 52: 193–198

  34. Yano K, Fukuda Y, Sumimoto R, Ito H, Asahara T and Dohi K (1995) Development of a rat model for orthotopic liver transplantation for hepatocellular carcinoma. Surgery 118: 539–546

Download references

Author information

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and Permissions

About this article

Cite this article

Yokoyama, H., Goto, S., Chen, C. et al. Major hepatic resection may suppress the growth of tumours remaining in the residual liver. Br J Cancer 83, 1096–1101 (2000) doi:10.1054/bjoc.2000.1379

Download citation

Keywords

  • HCC
  • hepatectomy
  • tumour growth
  • apoptosis
  • rat

Further reading